Christopher Russo
About Christopher Russo
Christopher Russo is the Associate Director of Cendakimab WW Medical at Bristol Myers Squibb in Princeton, New Jersey. He has extensive experience in the pharmaceutical industry, having previously worked at Pfizer and served as Adjunct Faculty at Rutgers University.
Current Role at Bristol Myers Squibb
Christopher Russo currently serves as the Associate Director for Cendakimab WW Medical at Bristol Myers Squibb in Princeton, New Jersey, United States. He has been in this role since June 2021, focusing on Cendakimab, a monoclonal antibody targeting IL-13.
Professional Experience at Pfizer
Before joining Bristol Myers Squibb, Christopher Russo worked at Pfizer as a Global Medical Affairs Senior Manager from 2019 to 2021 in Collegeville, PA. Prior to this role, he was a Postdoctoral Fellow at Pfizer from 2017 to 2019, gaining extensive experience in medical affairs.
Academic Role at Rutgers University
Alongside his industry roles, Christopher Russo served as an Adjunct Faculty member at Rutgers University from 2017 to 2019. This academic position complemented his professional responsibilities at Pfizer during the same period.
Early Career in Pharmacy
Christopher Russo's early career in pharmacy includes various internships and volunteer positions. He interned at multiple pharmacies, including AXON Communications, J&J Pharmacy, Stop and Shop Pharmacy, and True Care Pharmacy. Additionally, he gained volunteering experience at Good Samaritan Bon Secours Health System from 2012 to 2013.
Educational Background in Pharmacy
Christopher Russo holds a Doctor of Pharmacy (PharmD) from Long Island University, where he studied from 2013 to 2017. He also has a Post Doctoral Fellowship in Pharmaceutical Industry from Rutgers University, completed between 2017 to 2019. His foundational education includes an Associate of Science (AS) in Pre-Pharmacy Studies from Rockland Community College and a high school diploma from Spring Valley High School.